3Hanes SD,Wood GC,Herring V,et al.Intermittent and continuous ceftazidime infusion for critically ill trauma patients[J]. Am J Surg,2000,179:436-440
4Jones R. Resistance patterns among nosocomial pathogens[J]. Chest,2001,119:397-404
5Murthy R. Implementation of strategies to control antimcrobial resistance[J]. Chest,2001,119:405-411
6Leclercq R. Safeguarding future antimicrobial options: strategies to minimize resistance[J]. Clin Microbiol Infect,2001,7:18-23
7Raymond DP, Pelletier SJ,Crabtree TD,et al. Impact of rotating empiric antibiotic schedule on infectious mortality in an intensive care unit[J]. Crit Care Med,2001,29:1101-1108
8Dunbar,Lala M. Current Issues in the Management of Bacterial Respiratory Tract Disease: The challenge of antibacterial resistance[J]. The American Joural of Medical Science,2003,326⑹:360-368
9Niederman,Michael S. Appropriate use of antimicrobial agents:challenges and strategies for improvent[J]. Critical Care Medicine,2003,31⑵:608-616
二级参考文献10
1Lopez Antunano FJ,Silva Sanchez J. Archives of Medical Research . 1997
2Wolf son JS,Hooper DC. Clinical Microbiology Reviews . 1989
3Cullen ME et al. Antimicrobial Agents and Chemotherapy . 1989
4Shen LL et al. Biochemistry . 1989
5Williams JD,Moosdeen F. Reviews of Infectious Diseases . 1986
6Speer BS et al. Clinical Microbiology Reviews . 1992
7O‘Brien TF. Clinical Infectious Diseases . 1997
8Jenkins SG. New Horizons . 1996
9Jacoby GA,Archer GL. The New England Journal of Medicine . 1991
10DuBois SK et al. Journal of Antimicrobial Chemotherapy . 1995
